NCT Number: NCT00357019
Study of the Clinical and Biological Efficacity of NAAXIA SINE® in Vernal Keratoconjunctivitis
To assess the clinical and biological efficacity of preservative free NAAGA eyes drops in vernal keratoconjunctivitis
Looking for future studies?
Notify MeKey information
Conditions
Age range
4 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 4
About this study
The objective of this pilot study is to evaluate the clinical and biological efficacy of preservative free NAAGA eyedrops in VKC -by in particular the levels of ECP and MPO in tears- comparatively to the activity of levocabastine eyedrops.
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Patients with vernal keratoconjunctivitis,
- mild or moderate : clinical score >3 and <= 14, calculated from 4 major symptoms (itching, tearing, photophobia, foreign body sensation) and 6 major clinical signs (conjunctival erythema, conjunctival chemosis, discharge, papillae, limbal infiltrates and corneal epithelial disease)
- age >= 4 years old
Exclusion criteria
- no occurrence of ocular trauma or infection (within the 3 months preceding the study),
- no ocular medical treatment (topical or not) within the 5 days preceding the study,
- no ocular laser (within the 3 previous months),
- no ocular surgery (within the previous year),
- patient who signs the informed consent form (or his/her parents or legal guardian in the case of underage patient).
Treatment and study plan
Primary outcomes
-
ECP tear concentration
Secondary outcomes
-
Tolerance
Sponsors and collaborators
Lead sponsor
Laboratoires Thea
Industry
Registry information
Important dates
- Study start
- 2001
- Study completion
- 2002
- First posted
- Jul 27, 2006
- Registry last updated
- Jul 27, 2006
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Efficacy Study of FK-506 and Cyclosporine in Vernal Keratoconjunctivits (VKC)
NCT01068054
Conjunctival Diseases, Conjunctivitis
Bangkok, Thailand
View Trial DetailsThe INVIGORATE 2 Trial: A Clinical Trial to Assess the Efficacy and Safety of Subjects With Seasonal Allergic Conjunctivitis
NCT05234554
Allergic Conjunctivitis, Conjunctival Diseases
Mississauga, Ontario, Canada
View Trial DetailsA Study to Demonstrate How Well REGN1908-1909 Works in Reducing Ocular Allergy Signs and Symptoms in Adult Participants With Cat Allergy
NCT06602726
Allergic Conjunctivitis, Conjunctival Diseases
Andover, Massachusetts, United States
View Trial DetailsA Study to Demonstrate the Effect of REGN5713-5715 on Reducing Ocular Allergy Signs and Symptoms in Adult Participants With Birch Pollen Allergy
NCT06602739
Allergic Conjunctivitis, Conjunctival Diseases
Andover, Massachusetts, United States
View Trial Details